- Type / Class
- Equity / Common Stock
- Shares outstanding
- 152,309,909
- Total 13F shares
- 160,482,754
- Share change
- +3,913,075
- Total reported value
- $9,405,648,682
- Put/Call ratio
- 16%
- Price per share
- $58.63
- Number of holders
- 570
- Value change
- +$179,026,718
- Number of buys
- 273
- Number of sells
- 271
Quarterly Holders Quick Answers
What is CUSIP 09073M104?
CUSIP 09073M104 identifies TECH - BIO-TECHNE Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09073M104:
Top shareholders of TECH - BIO-TECHNE Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
18,594,608
|
$1,339,369,614 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
9.2%
|
14,036,494
|
$1,011,048,631 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7%
|
10,654,267
|
$767,428,000 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
6,472,680
|
$466,246,383 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.1%
|
4,758,525
|
$342,756,677 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.1%
|
4,702,942
|
$338,755,554 | — | 31 Dec 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
2.7%
|
4,136,984
|
$297,986,958 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
4,001,296
|
$287,488,334 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
2.5%
|
3,820,464
|
$275,188,021 | — | 31 Dec 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
2.4%
|
3,581,778
|
$257,995,476 | — | 31 Dec 2024 | |
| DF DENT & CO INC |
13F
|
Company |
2.1%
|
3,201,397
|
$230,596,631 | — | 31 Dec 2024 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
1.8%
|
2,758,070
|
$198,663,782 | — | 31 Dec 2024 | |
| MAIRS & POWER INC |
13F
|
Company |
1.8%
|
2,673,768
|
$192,591,494 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.7%
|
2,552,562
|
$183,861,041 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.6%
|
2,431,309
|
$175,127,227 | — | 31 Dec 2024 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
1.6%
|
2,419,654
|
$174,287,678 | — | 31 Dec 2024 | |
| Select Equity Group, L.P. |
13F
|
Company |
1.5%
|
2,335,359
|
$168,215,909 | — | 31 Dec 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.4%
|
2,183,779
|
$156,855,941 | — | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.3%
|
2,040,840
|
$147,001,705 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
1,906,162
|
$137,300,849 | — | 31 Dec 2024 | |
| BROWN CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,847,722
|
$133,091,416 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,758,074
|
$126,634,070 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,661,954
|
$119,710,546 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1%
|
1,522,693
|
$109,679,577 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.96%
|
1,465,690
|
$105,573,651 | — | 31 Dec 2024 | |
| Charles R. Kummeth |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,938,164
mixed-class rows
|
$103,771,891 | — | 15 Aug 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.94%
|
1,439,313
|
$103,673,715 | — | 31 Dec 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.86%
|
1,312,395
|
$94,531,815 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.74%
|
1,133,599
|
$81,653,116 | — | 31 Dec 2024 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
0.74%
|
1,127,380
|
$81,205,181 | — | 31 Dec 2024 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
1,089,935
|
$78,508,036 | — | 31 Dec 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
1,074,883
|
$77,423,822 | — | 31 Dec 2024 | |
| AMERICAN CAPITAL MANAGEMENT INC |
13F
|
Company |
0.7%
|
1,063,866
|
$76,630,268 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.68%
|
1,036,368
|
$74,649,588 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.66%
|
1,009,471
|
$72,712,370 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.63%
|
953,786
|
$68,704,751 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.62%
|
950,305
|
$68,450,450 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.61%
|
924,721
|
$66,607,654 | — | 31 Dec 2024 | |
| Ownership Capital B.V. |
13F
|
Company |
0.6%
|
906,813
|
$65,317,740 | — | 31 Dec 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.57%
|
860,751
|
$61,999,895 | — | 31 Dec 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.53%
|
801,625
|
$57,741,084 | — | 31 Dec 2024 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
0.5%
|
754,362
|
$54,336,678 | — | 31 Dec 2024 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.48%
|
734,675
|
$52,918,640 | — | 31 Dec 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.48%
|
736,340
|
$52,641,062 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.48%
|
727,805
|
$52,423,794 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.47%
|
717,222
|
$51,661,492 | — | 31 Dec 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.46%
|
704,625
|
$50,754,139 | — | 31 Dec 2024 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.45%
|
692,590
|
$49,887,258 | — | 31 Dec 2024 | |
| RIVERBRIDGE PARTNERS LLC |
13F
|
Company |
0.45%
|
686,722
|
$49,464,581 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.45%
|
681,981
|
$49,123,091 | — | 31 Dec 2024 |
Institutional Holders of BIO-TECHNE Corp - Common Stock (TECH) as of Q1 2025
As of 31 Mar 2025,
BIO-TECHNE Corp - Common Stock (TECH) was held by
570 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
160,482,754 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, MORGAN STANLEY, Select Equity Group, L.P., Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, and BAMCO INC /NY/.
This page lists
573
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
570
Q1 2025 holders
570
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.